HRT Financial buys 34,756 NewGenIvf shares

HRT Financial LP, a ten percent owner of NewGenIvf Group Ltd, reported open-market purchases of the company’s Common Stock.

Filing Impact

(Neutral)

Filing Sentiment

(Positive)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

HRT Financial LP, a ten percent owner of NewGenIvf Group Ltd, reported open-market purchases of the company’s Common Stock. On June 2, it bought 23,018 shares at an average price of $0.944 per share. On June 3, it bought an additional 11,738 shares at an average price of $0.875 per share. After these transactions, HRT Financial LP directly holds 83,079 shares of NewGenIvf common stock.

Insider Trade Summary

Net Buyer: 34,756 shares

Net Buy 2 txns

Insider HRT FINANCIAL LP

Role 10% Owner

Bought 34,756 shs ($32K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	11,738	$0.875	$10K
Purchase	Common Stock	23,018	$0.944	$22K

Holdings After Transaction: Common Stock — 83,079 shares (Direct)

Key Figures

Total shares bought: 34,756 shares June 2 purchase: 23,018 shares at $0.944/share June 3 purchase: 11,738 shares at $0.875/share +2 more

5 metrics

Total shares bought 34,756 shares Net open-market purchases reported in this Form 4

June 2 purchase 23,018 shares at $0.944/share Open-market buy of NewGenIvf Common Stock

June 3 purchase 11,738 shares at $0.875/share Open-market buy of NewGenIvf Common Stock

Holdings after trades 83,079 shares Direct ownership of NewGenIvf Common Stock after June 3

Insider role Ten percent owner HRT Financial LP status in NewGenIvf

Key Terms

open-market purchase, ten percent owner, Common Stock, Form 4

4 terms

open-market purchase financial

"transaction_action: "open-market purchase" for both Common Stock trades"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

ten percent owner regulatory

"HRT FINANCIAL LP is flagged as "is_ten_percent_owner": 1"

Common Stock financial

"security_title: "Common Stock" in both reported transactions"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"INSIDER FILING DATA (Form 4): { "issuerName": "NewGenIvf Group Ltd""

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did HRT Financial LP report for NIVF?

HRT Financial LP reported buying NewGenIvf (NIVF) Common Stock in the open market. It purchased 23,018 shares on June 2 and 11,738 shares on June 3, increasing its direct holdings to 83,079 shares after the transactions.

How many NewGenIvf (NIVF) shares did HRT Financial LP buy and at what prices?

HRT Financial LP bought a total of 34,756 NewGenIvf shares. It purchased 23,018 shares at an average price of $0.944 on June 2 and 11,738 shares at an average price of $0.875 on June 3 in open-market transactions.

What is HRT Financial LP’s ownership in NewGenIvf (NIVF) after these purchases?

After the reported open-market purchases, HRT Financial LP directly holds 83,079 shares of NewGenIvf Common Stock. The Form 4 identifies HRT Financial LP as a ten percent owner of the company, reflecting a significant shareholder position in NIVF.

Were the HRT Financial LP transactions in NIVF open-market purchases or another type?

The transactions were classified as open-market purchases of NewGenIvf Common Stock. Each trade carried the Form 4 code “P,” described as a purchase in an open market or private transaction, indicating straightforward buying activity rather than option exercises or gifts.

Did HRT Financial LP sell any NewGenIvf (NIVF) shares in this Form 4?

This Form 4 reports only buying activity by HRT Financial LP in NewGenIvf shares. The transaction summary shows two purchases totaling 34,756 shares, with no sales, gifts, tax withholdings, or derivative exercises disclosed in this particular filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/04/2026 - 04:08 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HRT FINANCIAL LP

(Last)

(First)

(Middle)

3 WORLD TRADE CENTER, 175 GREENWICH STRE

76TH FLOOR

(Street)

NEW YORK

10007

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NewGenIvf Group Ltd [ NIVF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/02/2026		P		23,018	A	$0.944	71,341	D
Common Stock	06/03/2026		P		11,738	A	$0.875	83,079	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

	Adam Nunes	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR